The Academy of Managed Care Pharmacy Annual Meeting kicked off on March 28, 2017, in Denver, Colorado, with a look at the specialty pharmaceutical pipeline with Aimee Tharaldson, PharmD, senior clinical consultant for emerging therapeutics at Express Scripts.
Source: Analyzing the Near-Term Pipeline for Specialty Drugs
Doxycycline is a cheap, widely available antibiotic. It is used to treat everything from acne to urinary tract infections. This humble little pill, we hav
Source: How We Discovered That A Common Antibiotic May Be Able To Treat Post-Traumatic Stress Disorder | IFLScience
Two Advisory Board research leaders discuss the current state of precision medicine – and what it will take for genomics to become part of routine care.
Source: 5 big challenges to utilizing genomic data for precision medicine | Healthcare IT News
Gene sequencing is cheaper and more prominent than ever before, but it’s still very early innings for this revolutionary technology.
Source: Genomics in Healthcare: A Game-Changer That’s Just Getting Started — The Motley Fool
Incredible breakthroughs in nanotechnology are driving 21st century progress. We look at Starpharma’s (SPHRY) VivaGel, which is doing just that in healthcare.
Source: How Nanotechnology is Changing the Face of Healthcare
Specialty pharmacies can collaborate with clinical teams to harness the power of health information technology and improve cancer care, according to panelists at the 5th annual Patient-Centered Oncology Care® meeting.
Source: Specialty Pharmacies Transforming Cancer Care
Cancer GenomicsGlioma brain tumors that carry mutant copies of the IDH gene can be subdivided into two major classes. However, the development of and differences between these two classes are not well characterized. Venteicher et al. coupled bulk sequencing and publicly available data with single-
Source: Effects of the tumor microenvironment | Science
The annual Rare Disease Day is designed to connect the rare disease community, build awareness and raise research funds.
Source: Tapping into the rare disease market | BioPharma Dive
Scientists discovered that DNA mutations and genome errors are top causes of cancers. This defies the theory that unhealthy lifestyle, smoking, among others are triggering cancer cells.
Source: DNA Mutations, Genome Errors Account For 66 Percent Of Cancer Risks: Unhealthy Lifestyle, Just Secondary Trigger : MEDICINE & HEALTH : Science Times
Researchers from the University of Nebraska develop a switch for HIV genomes to kick start the human immunity against the deadly virus.
Source: Scientists Genetically Engineered An HIV Genome To Develop Potential Vaccine : MEDICINE & HEALTH : Science Times